Non-viral gene-activated matrices: Next generation constructs for bone repair

Organogenesis

Volumn 9, Issue 1, 2013, Pages 22-28

  Tierney, Erica G ^a   Duffy, Garry P ^a,b   Cryan, Sally Ann ^a   Curtin, Caroline M ^a,b   O'Brien, Fergal J ^a,b  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Bone repair; Gene activated matrices; Mesenchymal stem cells; Non viral gene delivery vectors; Orthopaedic gene therapy; Regenerative medicine; Scaffolds; Tissue engineering

Indexed keywords

BONE MORPHOGENETIC PROTEIN 6; COLLAGEN; EPHRIN B2; EPHRIN RECEPTOR B4; PLASMID DNA; POLYETHYLENEIMINE; VIRUS VECTOR; TISSUE SCAFFOLD;

ADIPOSE TISSUE CELL; ADSORPTION; BONE DEFECT; BONE DEVELOPMENT; BONE REGENERATION; BONE REMODELING; CARTILAGE CELL; CELL MIGRATION; CELL STRUCTURE; CELL THERAPY; CELL VIABILITY; CELLS; CLINICAL TRIAL (TOPIC); FOCAL ADHESION; GENE ACTIVATED MATRIX; GENE EXPRESSION; HUMAN; IMMUNOGENICITY; IN VITRO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; NONVIRAL GENE THERAPY; OSSIFICATION; OSTEOCLASTOGENESIS; PHYSICAL PARAMETERS; REGENERATIVE MEDICINE; REVIEW; STEM CELL; TISSUE ENGINEERING; TISSUE REGENERATION; TRANSIENT EXPRESSION; ANIMAL; ARTICLE; CHEMISTRY; GENE THERAPY; GENE-ACTIVATED MATRICES; GENETIC TRANSFECTION; GENETICS; METABOLISM; NON-VIRAL GENE DELIVERY VECTORS; ORTHOPAEDIC GENE THERAPY; PHYSIOLOGY; SCAFFOLDS; VIRUS; VIRUS GENE;

BONE REPAIR; GENE-ACTIVATED MATRICES; MESENCHYMAL STEM CELLS; NON-VIRAL GENE DELIVERY VECTORS; ORTHOPAEDIC GENE THERAPY; REGENERATIVE MEDICINE; SCAFFOLDS; TISSUE ENGINEERING;

ANIMALS; BONE REGENERATION; EPHRIN-B2; GENE EXPRESSION; GENES, VIRAL; GENETIC THERAPY; HUMANS; TISSUE SCAFFOLDS; TRANSFECTION; VIRUSES;

EID: 84876566511     PISSN: 15476278     EISSN: 15558592     Source Type: Journal    
DOI: 10.4161/org.24329     Document Type: Review

References (65)

1. Williams DF. To engineer is to create: the link between engineering and regeneration. Trends Biotechnol 2006; 24:4-8; PMID:16289395; http://dx.doi.org/10.1016/j.tibtech.2005.10.006. (Pubitemid 43017744)
2. Yannas IV, Lee E, Orgill DP, Skrabut EM, Murphy GF. Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin. Proc Natl Acad Sci U S A 1989; 86:933-7; PMID:2915988; http://dx.doi.org/10.1073/pnas.86.3.933. (Pubitemid 19056266)
3. Yannas IV, Orgill DP, Burke JF. Template for skin regeneration. Plast Reconstr Surg 2011; 127(Suppl 1):60S-70S; PMID:21200274; http://dx.doi.org/10. 1097/PRS.0b013e318200a44d.
4. Raya-Rivera A, Esquiliano DR, Yoo JJ, Lopez-Bayghen E, Soker S, Atala A. Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet 2011; 377:1175-82; PMID:21388673; http://dx.doi.org/10.1016/S0140-6736(10)62354-9.
5. Badylak SF, Hoppo T, Nieponice A, Gilbert T W, Davison JM, Jobe BA. Esophageal preservation in five male patients after endoscopic inner-layer circumferential resection in the setting of superficial cancer: a regenerative medicine approach with a biologic scaffold. Tissue Eng Part A 2011; 17:1643-50; PMID:21306292; http://dx.doi.org/10.1089/ten.tea.2010.0739.
6. Macchiarini P, Jungebluth P, Go T, Asnaghi MA, Rees LE, Cogan TA, et al. Clinical transplantation of a tissue-engineered airway. Lancet 2008; 372:2023-30; PMID:19022496; http://dx.doi.org/10.1016/S0140-6736(08)61598-6.
7. Jungebluth P, Bader A, Baiguera S, Möller S, Jaus M, Lim ML, et al. The concept of in vivo airway tissue engineering. Biomaterials 2012; 33:4319-26; PMID:22440048; http://dx.doi.org/10.1016/j.bio-materials.2012.03.016.
8. Evans ND, Gentleman E, Polak JM. Scaffolds for stem cells. Mater Today 2006; 9:26-33; http://dx.doi.org/10.1016/S1369-7021(06)71740-0. (Pubitemid 44781424)
9. Keogh MB, O' Brien FJ, Daly JS. A novel collagen scaffold supports human osteogenesis-appli-cations for bone tissue engineering. Cell Tissue Res 2010; 340:169-77; PMID:20198386; http://dx.doi.org/10.1007/s00441-010-0939-y.
10. Tierney CM, Haugh MG, Liedl J, Mulcahy F, Hayes B, O'Brien FJ. The effects of collagen concentration and crosslink density on the biological, structural and mechanical properties of collagen-GAG scaffolds for bone tissue engineering. J Mech Behav Biomed Mater 2009; 2:202-9; PMID:19627824; http://dx.doi.org/10.1016/j.jmbbm.2008.08.007.
11. Murphy CM, Haugh MG, O'Brien FJ. The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering. Biomaterials 2010; 31:461-6; PMID:19819008; http://dx.doi.org/10.1016/j.biomaterials.2009.09.063.
12. Gleeson JP, Plunkett NA, O'Brien FJ. Addition of hydroxyapatite improves stiffness, interconnectivity and osteogenic potential of a highly porous collagenbased scaffold for bone tissue regeneration. Eur Cell Mater 2010 ; 20:218-30; PMID:20922667.
13. Al-Munajjed AA, Plunkett NA, Gleeson JP, Weber T, Jungreuthmayer C, Levingstone T, et al. Development of a biomimetic collagen-hydroxyapa-tite scaffold for bone tissue engineering using a SBF immersion technique. J Biomed Mater Res B Appl Biomater 2009; 90:584-91; PMID:19180526; http://dx.doi.org/10. 1002/jbm.b.31320.
14. Cunniffe GM, Dickson GR, Partap S, Stanton KT, O'Brien FJ. Development and characterisation of a collagen nano-hydroxyapatite composite scaffold for bone tissue engineering. J Mater Sci Mater Med 2010; 21:2293-8; PMID:20091099; http://dx.doi.org/10.1007/s10856-009-3964-1.
15. O'Brien FJ, Harley BA, Yannas IV, Gibson L. Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds. Biomaterials 2004; 25:1077-86; PMID:14615173; http://dx.doi.org/10.1016/S0142-9612(03)00630-6. (Pubitemid 37393297)
16. Cunniffe GM, O'Brien FJ, Partap S, Levingstone TJ, Stanton K T, Dickson GR. The synthesis and characterization of nanophase hydroxyapatite using a novel dispersant-aided precipitation method. J Biomed Mater Res A 2010; 95:1142-9; PMID:20878985; http://dx.doi.org/10.1002/jbm.a.32931.
17. Curtin CM, Cunniffe GM, Lyons FG, Bessho K, Dickson GR, Duffy GP, et al. Innovative collagen nano-hydroxyapatite scaffolds offer a highly efficient non-viral gene delivery platform for stem cellmediated bone formation. Adv Mater 2012; 24:749-54; PMID:22213347; http://dx.doi.org/10.1002/adma.201103828.
18. Lyons FG, Al-Munajjed AA, Kieran SM, Toner ME, Murphy CM, Duffy GP, et al. The healing of bony defects by cell-free collagen-based scaffolds compared to stem cell-seeded tissue engineered constructs. Biomaterials 2010; 31:9232-43; PMID:20863559; http://dx.doi.org/10.1016/j.bio-materials.2010.08.056.
19. Alhag M, Farrell E, Toner ME, Claffey N, Lee TC, O'Brien F. Evaluation of early healing events around mesenchymal stem cell-seeded collagen-gly- cosaminoglycan scaffold. An experimental study in Wistar rats. Oral Maxillofac Surg 2011; 15:31-9; PMID:20644972; http://dx.doi.org/10.1007/s10006-010-0241-x.
20. Alhag M, Farrell E, Toner M, Lee TC, O'Brien FJ, Claffey N. Evaluation of the ability of colla-gen-glycosaminoglycan scaffolds with or without mesenchymal stem cells to heal bone defects in Wistar rats. Oral Maxillofac Surg 2012; 16:47-55; PMID:21968608; http://dx.doi.org/10.1007/s10006-011-0299-0.
21. Bouard D, Alazard-Dany D, Cosset FL. Viral vectors: from virology to transgene expression. Br J Pharmacol 2009; 157:153-65; PMID:18776913; http://dx.doi.org/10.1038/bjp.2008.349.
22. Sheridan C. Gene therapy finds its niche. Nat Biotechnol 2011; 29:121-8; PMID:21301435; http://d x.doi.org/10.1038/nbt.1769.
23. Check E. A tragic setback. Nature 2002; 420:116-8; PMID:12432357; http://dx.doi.org/10.1038/420116a. (Pubitemid 35340095)
24. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 1999; 286:2244-5; PMID:10636774; http://dx.doi.org/10.1126/sci-ence.286. 5448.2244. (Pubitemid 30016842)
25. Takeda K. Delivery of magic bullets: on the still rocky road to gene therapy. Br J Pharmacol 2009; 157:151-2; PMID:19459842; http://dx.doi. o r g/10.1111/j.1476-53 81. 2 0 0 9. 0 0 2 89. x.
26. Ylä-Herttuala S. Endgame: glybera finally recommended for approval as the first gene therapy drug in the European union. Mol Ther 2012; 20:1831-2; PMID:23023051; http://dx.doi.org/10.1038/mt.2012.194.
27. Keeney M, van den Beucken JJJP, van der Kraan PM, Jansen JA, Pandit A. The ability of a collagen/calcium phosphate scaffold to act as its own vector for gene delivery and to promote bone formation via transfection with VEGF(165). Biomaterials 2010; 31:2893-902; PMID:20044134; http://dx.doi.org/10.1016/j. biomaterials.2009.12.041.
28. Endo M, Kuroda S, Kondo H, Maruoka Y, Ohya K, Kasugai S. Bone regeneration by modified gene-activated matrix: effectiveness in segmental tibial defects in rats. Tissue Eng 2006; 12:489-97; PMID:16579682; http://dx.doi.org/10.1089/ten.2006.12.489. (Pubitemid 43673454)
29. Itaka K, Ohba S, Miyata K, Kawaguchi H, Nakamura K, Takato T, et al. Bone regeneration by regulated in vivo gene transfer using biocompatible polyplex nanomicelles. Mol Ther 2007; 15:1655-62; PMID:17551504; http://dx.doi.org/10. 1038/sj.mt.6300218. (Pubitemid 47289009)
30. Evans CH. Gene therapy for bone healing. Expert Rev Mol Med 2010; 12:e18; PMID:20569532; http://dx.doi.org/10.1017/S1462399410001493.
31. Evans CH. Barriers to the clinical translation of orthopedic tissue engineering. Tissue Eng Part B Rev 2011; 17:437-41; PMID:21682607; http://dx.doi.org/10.1089/ten.teb.2011.0228.
32. Evans CH, Ghivizzani SC, Robbins PD. Orthopedic gene therapy-lost in translation? J Cell Physiol 2012; 227:416-20; PMID:21948071; http://dx.doi.org/10.1002/jcp.23031.
33. Sheyn D, Mizrahi O, Benjamin S, Gazit Z, Pelled G, Gazit D. Genetically modified cells in regenerative medicine and tissue engineering. Adv Drug Deliv Rev 2010; 62:683-98; PMID:20114067; http://dx.doi.org/10.1016/j.addr.2010.01. 002.
34. Santos JL, Pandita D, Rodrigues J, Pêgo A P, Granja PL, Tomás H. Non-viral gene delivery to mesenchy-mal stem cells: methods, strategies and application in bone tissue engineering and regeneration. Curr Gene Ther 2011; 11:46-57; PMID:21182464; http://dx.doi.org/10.2174/ 156652311794520102.
35. Midoux P, Pichon C, Yaouanc JJ, Jaffrès PA. Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers. Br J Pharmacol 2009; 157:166-78; PMID:19459843; http://dx.doi. o r g/10.1111/j.1476-5381. 2 0 0 9.0 0 2 8 8. x.
36. Bonadio J, Smiley E, Patil P, Goldstein S. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 1999; 5:753-9; PMID:10395319; http://dx.doi.org/10.1038/ 10473. (Pubitemid 29318608)
37. Fang J, Zhu Y Y, Smiley E, Bonadio J, Rouleau JP, Goldstein SA, et al. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci U S A 1996; 93:5753-8; PMID:8650165; http://dx.doi.org/10.1073/pnas.93.12.5753. (Pubitemid 26190752)
38. Wan ACA, Ying JY. Nanomaterials for in situ cell delivery and tissue regeneration. [Corrected Proof.]. Adv Drug Deliv Rev 2010; 62:731-40; PMID:20156499; http://dx.doi.org/10.1016/j. addr.2010.02.002.
39. Martinek V, Latterman C, Usas A, Abramowitch S, Woo SL, Fu FH, et al. Enhancement of tendon-bone integration of anterior cruciate ligament grafts with bone morphogenetic protein-2 gene transfer: a his-tological and biomechanical study. J Bone Joint Surg Am 2002; 84-A:1123-31; PMID:12107310.
40. Madry H, Kaul G, Cucchiarini M, Stein U, Zurakowski D, Remberger K, et al. Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). Gene Ther 2005; 12:1171-9; PMID:15815701; http://dx.doi.org/10.1038/sj.gt.3302515. (Pubitemid 41136311)
41. Guo T, Zhao J, Chang J, Ding Z, Hong H, Chen J, et al. Porous chitosan-gelatin scaffold containing plasmid DNA encoding transforming growth factor-beta1 for chondrocytes proliferation. Biomaterials 2006; 27:1095-103; PMID:16143394; http://dx.doi.org/10.1016/j.biomaterials.2005.08.015. (Pubitemid 41566703)
42. Babister JC, Tare RS, Green DW, Inglis S, Mann S, Oreffo RO. Genetic manipulation of human mesen-chymal progenitors to promote chondrogenesis using "bead-in-bead" polysaccharide capsules. Biomaterials 2008; 29:58-65; PMID:17897711; http://dx.doi.org/10.1016/j.biomaterials.2007.09.006. (Pubitemid 47610692)
43. Gelse K, Mühle C, Franke O, Park J, Jehle M, Durst K, et al. Cell-based resurfacing of large cartilage defects: long-term evaluation of grafts from autologous transgene-activated periosteal cells in a porcine model of osteoarthritis. Arthritis Rheum 2008; 58:475-88; PMID:18240212; http://dx.doi.org/10.1002/art.23124. (Pubitemid 351294882)
44. Kayabaşi GK, Tişli Aydin RS, Gümüş derelioşlu M. In vitro chondrogenesis by BMP6 gene therapy. J Biomed Mater Res A 2013; 101:1353-61; PMID:23077084; http://dx.doi.org/10.1002/jbm.a. 34430.
45. Jaiswal RK, Jaiswal N, Bruder SP, Mbalaviele G, Marshak DR, Pittenger MF. Adult human mesen-chymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-acti-vated protein kinase. J Biol Chem 2000; 275:9645-52; PMID:10734116; http://dx.doi.org/10.1074/jbc.275.13. 9645. (Pubitemid 30185197)
46. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143-7; PMID:10102814; http://dx.doi.org/10.1126/scienc e.284.5411.143. (Pubitemid 29282067)
47. Tierney EG, Duffy GP, Hibbitts AJ, Cryan S-A, O'Brien FJ. The development of non-viral gene-activated matrices for bone regeneration using poly-ethyleneimine (PEI) and collagen-based scaffolds. J Control Release 2012; 158:304-11; PMID:22138069; http://dx.doi.org/10.1016/j.jconrel.2011.11.026.
48. Nguyen YT, Kim HK, Kwon JS, Kim YS, Yoon TR, Ahn Y, et al. Efficient transfer of reporter gene-loaded nanoparticles to bone marrow stromal cells (D1) by reverse transfection. J Nanosci Nanotechnol 2010; 10:3170-4; PMID:20358915; http://dx.doi.org/10.1166/jnn.2010.2236.
49. Tripathi SK, Goyal R, Kumar P, Gupta KC. Linear polyethylenimine-graft- chitosan copo-lymers as efficient DNA/siRNA delivery vectors in vitro and in vivo. Nanomedicine 2012; 8:337-45; PMID:21756861; http://dx.doi.org/10.1016/j. nano.2011.06.022.
50. Huang YC, Connell M, Park Y, Mooney DJ, Rice KG. Fabrication and in vitro testing of polymeric delivery system for condensed DNA. J Biomed Mater Res A 2003; 67:1384-92; PMID:14624526; http://dx.doi.org/10.1002/jbm.a.20036. (Pubitemid 37522753)
51. Wang W, Li W, Ou L, Flick E, Mark P, Nesselmann C, et al. Polyethylenimine-mediated gene delivery into human bone marrow mesenchymal stem cells from patients. J Cell Mol Med 2011; 15:1989-98; PMID: 20629995 ; htt p://dx.doi.org/10.1111/j.1582-4934.2010.01130.x.
52. Huang YC, Riddle K, Rice KG, Mooney DJ. Longterm in vivo gene expression via delivery of PEI-DNA condensates from porous polymer scaffolds. Hum Gene Ther 2005; 16:609-17; PMID:15916485; http://dx.doi.org/10.1089/hum.2005.16.609. (Pubitemid 40740928)
53. Kong HJ, Liu J, Riddle K, Matsumoto T, Leach K, Mooney DJ. Non-viral gene delivery regulated by stiffness of cell adhesion substrates. Nat Mater 2005; 4:460-4; PMID:15895097; http://dx.doi.org/10.1038/nmat1392. (Pubitemid 40774051)
54. Rao R. R., He J, Leach JK. Biomineralized composite substrates increase gene expression with nonviral delivery. J Biomed Mater Res A 2010; 94A:344-54.
55. Grochowsky JC, Alaways LW, Siskey R, Most E, Kurtz SM. Digital photogrammetry for quantitative wear analysis of retrieved TKA components. J Biomed Mater Res B Appl Biomater 2006; 79:263-7; PMID:16649169; http://dx.doi.org/10.1002/jbm.b.30537. (Pubitemid 44652050)
56. Tierney EG, McSorley K, Hastings CL, Cryan S-A, O'Brien T, Murphy MJ, et al. High levels of ephrinB2 over-expression increases the osteogenic differentiation of human mesenchymal stem cells and promotes enhanced cell mediated mineralisation in a polyethyl-eneimine-ephrinB2 gene-activated matrix. J Control Release 2013; 165:173-82; PMID:23201622; http://d x.doi.org/10.1016/j. jconrel.2012.11.013.
57. Poliakov A, Cotrina M, Wilkinson DG. Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly. Dev Cell 2004; 7:465-80; PMID:15469835; http://dx.doi.org/10.1016/j.devcel.2004.09.006. (Pubitemid 39341833)
58. Klein R. Eph/ephrin signaling in morphogenesis, neural development and plasticity. Curr Opin Cell Biol 2004; 16:580-9; PMID:15363810; http://dx.doi.org/10.1016/j.ceb.2004.07.002. (Pubitemid 39201244)
59. Zhao C, Irie N, Takada Y, Shimoda K, Miyamoto T, Nishiwaki T, et al. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab 2006; 4:111-21; PMID:16890539; http://dx.doi.org/10.1016/j.cmet.2006.05.012. (Pubitemid 44138718)
60. Allan EH, Häusler KD, Wei T, Gooi JH, Quinn JMW, Crimeen-Irwin B, et al. EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts. J Bone Miner Res 2008; 23:1170-81; PMID:18627264; http://dx.doi.org/10.1359/jbmr.080324. (Pubitemid 352040173)
61. Pasquale EB. Eph-ephrin bidirectional signaling in physiology and disease. Cell 2008; 133:38-52; PMID:18394988; http://dx.doi.org/10.1016/j. cell.2008.03.011. (Pubitemid 351442996)
62. Huebsch N, Mooney DJ. Inspiration and application in the evolution of biomaterials. Nature 2009; 462:426-32; PMID:19940912; http://dx.doi.org/10.1038/ nature08601.
63. Yu NY, Schindeler A, Tagil M, Ruys AJ, Little DG. Use of BMPs and bisphosphonates in improving bone fracture healing. [Elite Ed]. Front Biosci (Elite Ed) 2012; 4:2647-53; PMID:22652667; http://dx.doi.org/10.2741/E572.
64. Duffy GP, D'Arcy S, Ahsan T, Nerem RM, O'Brien T, Barry F. Mesenchymal stem cells overexpress-ing ephrin-b2 rapidly adopt an early endothelial phenotype with simultaneous reduction of osteo-genic potential. Tissue Eng Part A 2010; 16:2755-68; PMID:20491587; http://dx.doi.org/10.1089/ten. tea.2009.0623.
65. Orrantia E, Chang PL. Intracellular distribution of DNA internalized through calcium phosphate precipitation. Exp Cell Res 1990; 190:170-4; PMID:2209719; http://dx.doi.org/10.1016/0014-4827(90)90181-9.